Wanbury Stock Screener | Share Price & Fundamental Analysis
WANBURY
Pharmaceuticals
Share Price NSE
₹263.28
▼
-8.53 (-3.14%)
Share Price BSE
₹248.15
▲
7.70 (3.20%)
As of February 24, 2026, the Wanbury share price (NSE: WANBURY) is ₹263.28 on NSE and ₹248.15 on BSE, down 3.14% from the previous close, with shares trading between ₹257.13 and ₹271.81, and a 52-week range of ₹163.34–₹312.65.
Browse Wanbury financial data to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Wanbury Market Cap
₹879.91 Cr.
WANBURY P/E Ratio (TTM)
19.55
Wanbury P/B Ratio
10.85
EPS (TTM)
₹9.32
Dividend Yield
-
Debt to Equity
3.38
WANBURY 52 Week High
₹312.65
Wanbury 52 Week Low
₹163.34
Operating Margin
17.00%
Profit Margin
11.49%
WANBURY Revenue (TTM)
₹174.00
EBITDA
₹32.00
Net Income
₹20.00
Total Assets
₹414.00
Total Equity
₹59.00
Wanbury Share Price History - Stock Screener Chart
Screen WANBURY historical share price movements with interactive charts. Analyze price trends and patterns.
Wanbury Company Profile - Fundamental Screener
Screen Wanbury company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for WANBURY shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE107F01022
Wanbury Balance Sheet Screener
Screen WANBURY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 414 | 343 | 304 | 353 | 289 | 279 | 286 | 273 | 412 | 388 |
| Current Assets | 193 | 159 | 122 | 171 | 98 | 90 | 94 | 74 | 192 | 164 |
| Fixed Assets | 201 | 167 | 167 | 167 | 167 | 164 | 172 | 178 | 186 | 180 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 180 | 105 | 16 | 16 | 90 | 111 | 134 | 109 | 163 | 251 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 59 | 28 | -33 | -23 | -156 | -144 | -209 | -185 | -153 | -162 |
| Share Capital | 33 | 33 | 33 | 33 | 25 | 25 | 24 | 24 | 23 | 20 |
| Reserves & Surplus | 21 | -11 | -66 | -56 | -181 | -168 | -233 | -208 | -177 | -221 |
Wanbury Income Statement Screener - Profit & Revenue Analysis
Screen Wanbury income statement and profit fundamentals.
Analyze WANBURY quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Wanbury share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec | 2021-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 174 | 164 | 166 | 132 | 163 | 134 | 131 | 147 | 145 | 146 | 211 | 119 | 125 | 126 | 122 |
| Expenses | 142 | 139 | 121 | 120 | 141 | 120 | 119 | 133 | 127 | 124 | 122 | 120 | 118 | 119 | 122 |
| EBITDA | 32 | 25 | 45 | 12 | 22 | 15 | 12 | 14 | 18 | 22 | 90 | -1 | 6 | 7 | -1 |
| Operating Profit % | 17.00% | 15.00% | 13.00% | 8.00% | 12.00% | 10.00% | 10.00% | 9.00% | 12.00% | 15.00% | 10.00% | -3.00% | 5.00% | 5.00% | -1.00% |
| Depreciation | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 9 | 8 | 8 | 8 | 10 | 10 | 8 | 6 | 8 | 8 | 5 | 3 | 4 | 7 | 6 |
| Profit Before Tax | 19 | 14 | 34 | 1 | 8 | 1 | 1 | 5 | 7 | 10 | 82 | -7 | -1 | -3 | -9 |
| Tax | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Net Profit | 20 | 14 | 34 | 1 | 8 | 1 | 1 | 5 | 7 | 10 | 83 | -7 | -1 | -3 | -9 |
| EPS | 6.18 | 4.12 | 10.28 | 0.32 | 2.44 | 0.38 | 0.31 | 1.43 | 2.25 | 3.14 | 25.62 | -2.22 | -0.27 | -1.00 | -3.58 |
Wanbury Cash Flow Screener - Liquidity Fundamentals
Screen WANBURY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 26 | 5 | 20 | 41 | 17 | 44 | 30 | 33 | 43 | 43 |
| Investing Activities | -51 | -17 | -9 | 1 | 8 | 64 | -3 | -1 | -13 | -20 |
| Financing Activities | 26 | 14 | -32 | -29 | -17 | -108 | -27 | -33 | -27 | -28 |
| Net Cash Flow | 1 | 2 | -21 | 13 | 7 | 0 | 0 | -2 | 3 | -5 |
Wanbury Shareholding Pattern Screener
See Wanbury shareholding pattern with promoter, FII, and DII holdings.
Check Wanbury promoter holding and ownership changes for WANBURY on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 39.76% | 39.63% | 43.09% | 43.07% | 39.79% | 39.79% | 39.77% | 39.76% |
| FII Holding | 1.55% | 1.59% | 0.82% | 0.72% | 0.18% | 0.22% | 1.02% | 0.84% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 41.78% | 42.06% | 41.19% | 41.28% | 41.81% | 41.42% | 40.66% | 39.61% |
| Other Holding | 16.90% | 16.71% | 14.89% | 14.92% | 18.22% | 18.57% | 18.54% | 19.79% |
| Shareholder Count | 17,889 | 17,894 | 17,717 | 17,261 | 13,087 | 14,400 | 17,199 | 17,999 |
Wanbury Share Dividend Screener - Share Yield Analysis
Check Wanbury dividend history with payout and yield data.
View Wanbury dividend details including ex-dates and amounts for WANBURY stock.
Wanbury Stock Index Membership
See which indices include Wanbury stock.
Check WANBURY index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Wanbury Market Events Screener - Corporate Actions
Get Wanbury corporate actions including splits, bonuses, and buybacks.
Check Wanbury stock events that may affect WANBURY share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -12.35% | ||
| Annual General Meeting | NA | 27.65% | ||
| Annual General Meeting | NA | 15.79% | ||
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 58.44% |
| 2026-01-05 | 2026-01-05 | Extraordinary General Meeting | NA | 1.20% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -8.84% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | 9.64% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 11.57% |
| 2025-02-20 | 2025-02-20 | Extraordinary General Meeting | NA | -25.55% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -11.84% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 10.56% |
| 2023-08-21 | 2023-08-21 | Extraordinary General Meeting | NA | 3.28% |
Wanbury Competitors Screener - Peer Comparison
Screen WANBURY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 396,418 | 36.25 | 54,729 | 9.71% | 10,980 | 33.68 |
| Divis Laboratories | 161,139 | 65.53 | 9,712 | 18.67% | 2,191 | 50.76 |
| Torrent Pharmaceuticals | 141,504 | 61.93 | 11,539 | 6.99% | 1,911 | 49.76 |
| Lupin | 105,810 | 22.84 | 22,910 | 13.74% | 3,306 | 53.72 |
| Dr Reddys Laboratories | 103,154 | 18.62 | 33,741 | 16.73% | 5,725 | 46.43 |
| Cipla | 97,830 | 21.91 | 28,410 | 7.12% | 5,291 | 36.48 |
| Zydus Life Science | 92,815 | 18.33 | 23,511 | 18.55% | 4,615 | 59.14 |
| Mankind Pharma | 85,756 | 47.59 | 12,744 | 20.90% | 2,007 | 51.41 |
| Aurobindo Pharma | 77,816 | 22.50 | 32,346 | 9.43% | 3,484 | 62.63 |
| Alkem Laboratories | 64,141 | 26.85 | 13,458 | 3.70% | 2,216 | 49.73 |
Wanbury Company Announcements - News Screener
Screen WANBURY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-09 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-05 | Outcome Of The Board Meeting Held On 05-02-2026 - Grant Of 60000 Stock Options (ESOPs) To The Employees Of The Company. | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-02-05 | Financial Results For Quarter Ended 31St December 2025 | - |
| 2026-02-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On February 05 2026 | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-28 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-01-05 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2025-12-29 | Closure of Trading Window | - |
| 2025-12-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-12-12 | Notice Of Book Closure For The Purpose Of Extra-Ordinary General Meeting (EOGM) To Be Held On 5Th January 2026 Through Video Conferencing (VC) / Other Audio Visual Means (OAVM). | - |